Skip to main content
Log in

IL-2 induces the release of secondary cytokines which stimulate the cytotoxic activity of either NK or CD8+ lymphocytes

  • Invited Lecture
  • Published:
Cytotechnology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Rosenberg S.A. (1986). Adoptive immunotherapy of cancer using lymphokine-activated killer cells and interleukin-2 in V.T.DeVita, S.Hellman and S.A.Rosenberg (eds.), Important Advances in Oncology, J. B. Lippincott Company Publisher, Philadelphia, pp. 55–91.

    Google Scholar 

  2. Grimm E.A., Mazunider A., Zhang H.Z. and Rosenberg S.A. (1984). The lymphokine activated killer cell phenomenon: lysis of NK resistant fresh solid tumor cells by IL-2 activated autologous human peripheral blood lymphocytes. J. Exp. Med. 155, 1823–1841.

    Google Scholar 

  3. Rosenberg S.A., Lotze M.T., Muul L.M. (1987). A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N. Engl. J. Med. 316, 889–897.

    Google Scholar 

  4. Lotze M.T., Matori Y.L., Ettinghausen S.E., Rajner A.A., Sharrow S.O., Seipp C.A., Custer M.C. and Rosenberg S.A. (1985). In vivo administration of peripheral human interleukin-2. J. Immunol. 135, 2865–2875.

    Google Scholar 

  5. Ettinghausen S.E., Moore J.G., White D.E. and Rosenberg S.A. (1987). Hematological effects of immunotherapy with lymphokine-activated killer cells and recombinant interleukin-2 in cancer patients. Blood 69, 1654–1660.

    Google Scholar 

  6. Tritarelli E., Rocca E., Testa U., Boccoli G., Camagna A., Calabresi F. and Peschle C. (1990). Adoptive immunotherapy with high-dose interleukin-2: kinetics of circulating progenitors correlate with IL-6, G-CSF levels. Blood (in press).

  7. Mier J.K., Vachino G., Van DerHeer J.W., Numerof R.P., Adams S., Cannon J.G., Beinheon H.A., Atkins M.B., Parkinson D.R., Dinarello C.A. (1988). Induction of circulating tumor necrosis factor (TNF-alpha) as the mechanism for the febrile response to interleukin-2 in cancer patients. J. Clin. Immunol. 8: 426–436.

    Google Scholar 

  8. Boccoli G., Masciulli R., Ruggeri E.M., Carlini P., Giannella G., Montesoro E., Isacchi G., Testa U., Calabresi F., Peschle C. (1990). Adoptive immunotherapy of human cancer: the cytokine cascade and monocyte activation following high-dose interleukin-2 bolus treatment. Cancer Res. 50: 5795–5800.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Testa, U., Bulgarini, D., Montesoro, E. et al. IL-2 induces the release of secondary cytokines which stimulate the cytotoxic activity of either NK or CD8+ lymphocytes. Cytotechnology 5 (Suppl 1), 126–129 (1991). https://doi.org/10.1007/BF00736828

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00736828

Keywords

Navigation